- $1.58bn
- $4.51bn
- $4.19bn
- 31
- 77
- 47
- 51
Annual balance sheet for Calumet, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 109 | 38.1 | 35.2 | 7.9 | 38.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 160 | 253 | 268 | 286 | 278 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 535 | 633 | 820 | 795 | 766 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,006 | 1,107 | 1,590 | 1,621 | 1,679 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,808 | 2,128 | 2,742 | 2,751 | 2,758 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 545 | 900 | 1,352 | 1,113 | 864 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,937 | 2,513 | 3,280 | 3,242 | 3,470 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -129 | -385 | -538 | -490 | -712 |
| Total Liabilities & Shareholders' Equity | 1,808 | 2,128 | 2,742 | 2,751 | 2,758 |
| Total Common Shares Outstanding |